Your browser doesn't support javascript.
loading
A novel miR1983-TLR7-IFNß circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1.
Shah, Diana; Comba, Andrea; Faisal, Syed M; Kadiyala, Padma; Baker, Gregory J; Alghamri, Mahmoud S; Doherty, Robert; Zamler, Daniel; Nuñez, Gabriel; Castro, Maria G; Lowenstein, Pedro R.
Afiliação
  • Shah D; Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Comba A; Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Faisal SM; Rogel Cancer Center, University of Michigan, Ann Arbor, MI USA.
  • Kadiyala P; Cancer Biology Training Program, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Baker GJ; Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Alghamri MS; Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Doherty R; Rogel Cancer Center, University of Michigan, Ann Arbor, MI USA.
  • Zamler D; Cancer Biology Training Program, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Nuñez G; Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Castro MG; Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Lowenstein PR; Rogel Cancer Center, University of Michigan, Ann Arbor, MI USA.
Oncoimmunology ; 10(1): 1939601, 2021.
Article em En | MEDLINE | ID: mdl-34249474

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Galectina 1 / Receptor 7 Toll-Like / Glioma Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Galectina 1 / Receptor 7 Toll-Like / Glioma Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos